Ann Cunningham
Director/Board Member at VISTAGEN THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Ann Cunningham active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Director/Board Member | 2019-01-09 | - |
| Independent Dir/Board Member | 2019-01-09 | - | |
| Corporate Officer/Principal | 2021-04-30 | 2022-10-31 |
Career history of Ann Cunningham
Former positions of Ann Cunningham
| Companies | Position | Start | End |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 2014-12-31 | 2017-12-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 1998-12-31 | 2012-12-31 |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - | - |
| I3 Strategy Partners LLC | Founder | - | - |
| Corporate Officer/Principal | - | - |
Training of Ann Cunningham
| Yale University | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Statistics
International
| United States | 7 |
| Israel | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
| I3 Strategy Partners LLC |
- Stock Market
- Insiders
- Ann Cunningham
- Experience
